Report Summary
Eternity Insights has published a new study on Global Rheumatoid Arthritis (RA) Drugs Market focusing on key segments as by Type (Oral, Injection, External, Other), by Application (Medical Care, Personal Care, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Rheumatoid Arthritis (RA) Drugs Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Rheumatoid Arthritis (RA) Drugs Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Rheumatoid Arthritis (RA) Drugs Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Rheumatoid Arthritis (RA) Drugs Market Segmentation:
Rheumatoid Arthritis (RA) Drugs Market, By Type
- Oral
- Injection
- External
- Other
Rheumatoid Arthritis (RA) Drugs Market, By Application
- Medical Care
- Personal Care
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Rheumatoid Arthritis (RA) Drugs market in terms of demand generation. The Rheumatoid Arthritis (RA) Drugs market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Rheumatoid Arthritis (RA) Drugs market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Rheumatoid Arthritis (RA) Drugs Market Taxonomy:
To learn more about this report
Global Rheumatoid Arthritis (RA) Drugs Market Competitive Landscape
The global Rheumatoid Arthritis (RA) Drugs market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- AbbVie
- Roche
- Johnson & Johnson
- Amgen
- Inc.
- Pfizer
- Merck
- Bristol-Myers Squibb
- UCB
- GlaxoSmithKline
- Sanofi
- Abbott Laboratories
- Teva Pharmaceutical
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Oral, Injection, External, Other |
| By Application Outlook |
Medical Care, Personal Care, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
AbbVie, Roche, Johnson & Johnson, Amgen, Inc., Pfizer, Merck, Bristol-Myers Squibb, UCB, GlaxoSmithKline, Sanofi, Abbott Laboratories, Teva Pharmaceutical |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size Growth Rate by Type (2017-2027)
1.4.2 Oral
1.4.3 Injection
1.4.4 External
1.5 Market by Application
1.5.1 Global Rheumatoid Arthritis (RA) Drugs Market Share by Application (2017-2027)
1.5.2 Medical Care
1.5.3 Personal Care
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Rheumatoid Arthritis (RA) Drugs Market Size
2.2 Rheumatoid Arthritis (RA) Drugs Growth Trends by Regions
2.2.1 Rheumatoid Arthritis (RA) Drugs Market Size by Regions (2017-2027)
2.2.2 Rheumatoid Arthritis (RA) Drugs Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Rheumatoid Arthritis (RA) Drugs Market Size by Manufacturers
3.1.1 Global Rheumatoid Arthritis (RA) Drugs Revenue by Manufacturers (2017-2020)
3.1.2 Global Rheumatoid Arthritis (RA) Drugs Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Rheumatoid Arthritis (RA) Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Rheumatoid Arthritis (RA) Drugs Key Players Head office and Area Served
3.3 Key Players Rheumatoid Arthritis (RA) Drugs Product/Solution/Service
3.4 Date of Enter into Rheumatoid Arthritis (RA) Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Rheumatoid Arthritis (RA) Drugs Market Size by Type (2017-2020)
4.2 Global Rheumatoid Arthritis (RA) Drugs Market Size by Application (2017-2020)
5 United States
5.1 United States Rheumatoid Arthritis (RA) Drugs Market Size (2017-2020)
5.2 Rheumatoid Arthritis (RA) Drugs Key Players in United States
5.3 United States Rheumatoid Arthritis (RA) Drugs Market Size by Type
5.4 United States Rheumatoid Arthritis (RA) Drugs Market Size by Application
6 Europe
6.1 Europe Rheumatoid Arthritis (RA) Drugs Market Size (2017-2020)
6.2 Rheumatoid Arthritis (RA) Drugs Key Players in Europe
6.3 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Type
6.4 Europe Rheumatoid Arthritis (RA) Drugs Market Size by Application
7 China
7.1 China Rheumatoid Arthritis (RA) Drugs Market Size (2017-2020)
7.2 Rheumatoid Arthritis (RA) Drugs Key Players in China
7.3 China Rheumatoid Arthritis (RA) Drugs Market Size by Type
7.4 China Rheumatoid Arthritis (RA) Drugs Market Size by Application
8 Japan
8.1 Japan Rheumatoid Arthritis (RA) Drugs Market Size (2017-2020)
8.2 Rheumatoid Arthritis (RA) Drugs Key Players in Japan
8.3 Japan Rheumatoid Arthritis (RA) Drugs Market Size by Type
8.4 Japan Rheumatoid Arthritis (RA) Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size (2017-2020)
9.2 Rheumatoid Arthritis (RA) Drugs Key Players in Southeast Asia
9.3 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size by Type
9.4 Southeast Asia Rheumatoid Arthritis (RA) Drugs Market Size by Application
10 India
10.1 India Rheumatoid Arthritis (RA) Drugs Market Size (2017-2020)
10.2 Rheumatoid Arthritis (RA) Drugs Key Players in India
10.3 India Rheumatoid Arthritis (RA) Drugs Market Size by Type
10.4 India Rheumatoid Arthritis (RA) Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Rheumatoid Arthritis (RA) Drugs Market Size (2017-2020)
11.2 Rheumatoid Arthritis (RA) Drugs Key Players in Central & South America
11.3 Central & South America Rheumatoid Arthritis (RA) Drugs Market Size by Type
11.4 Central & South America Rheumatoid Arthritis (RA) Drugs Market Size by Application
12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.1.4 AbbVie Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.1.5 AbbVie Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.2.4 Roche Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.2.5 Roche Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.3.4 Johnson & Johnson Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.3.5 Johnson & Johnson Recent Development
12.4 Amgen, Inc.
12.4.1 Amgen, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.4.4 Amgen, Inc. Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.4.5 Amgen, Inc. Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.5.4 Pfizer Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.5.5 Pfizer Recent Development
12.6 Merck
12.6.1 Merck Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.6.4 Merck Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.6.5 Merck Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.7.4 Bristol-Myers Squibb Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.7.5 Bristol-Myers Squibb Recent Development
12.8 UCB
12.8.1 UCB Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.8.4 UCB Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.8.5 UCB Recent Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.9.4 GlaxoSmithKline Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.9.5 GlaxoSmithKline Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rheumatoid Arthritis (RA) Drugs Introduction
12.10.4 Sanofi Revenue in Rheumatoid Arthritis (RA) Drugs Business (2017-2020)
12.10.5 Sanofi Recent Development
12.11 Abbott Laboratories
12.12 Teva Pharmaceutical
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
